Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.

ABSTRACT:

Background

The widespread use of vaccines against the novel coronavirus disease (COVID-19) has become one of the most effective means to establish a population immune barrier. Patients with cancer are vulnerable to COVID-19 infection, adverse events, and high mortality, and should be the focus of epidemic prevention and treatment. However, real-world data on the safety of vaccines for patients with breast cancer are still scarce.

Objective

This study aims to compare the safety of COVID-19 vaccines between patients vaccinated before or after being diagnosed with breast cancer.

Methods

Patients with breast cancer who sought medical advice from October 2021 to December 2021 were screened. Those who received COVID-19 vaccines were enrolled in this study to analyze the saf

SUBMITTER: Zhang S 

PROVIDER: S-EPMC10739232 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature